A patient on ARB blockers may experience which of the following?

Patients on angiotensin II receptor blockers (ARBs) are commonly monitored for hyperkalemia, which is an elevated potassium level in the blood. ARBs block the action of angiotensin II, a peptide that plays a crucial role in regulating blood pressure and electrolyte balance. By doing so, ARBs can lead to reduced aldosterone secretion, which is the hormone responsible for potassium excretion in the kidneys. As a result, the renal handling of potassium may be altered, causing higher levels of potassium to accumulate in the bloodstream, leading to hyperkalemia.

Understanding the specific side effect profile of ARBs is essential in managing patients who are prescribed these medications. Monitoring serum potassium levels is often recommended to prevent complications associated with hyperkalemia, such as cardiac arrhythmias.